Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fungal beta-xylosidase is a critical glycoside hydrolase enzyme responsible for the hydrolysis of (1->4)-beta-D-xylans, releasing successive D-xylose residues from the non-reducing termini of xylo-oligosaccharides [1]. This enzyme is essential for the complete saccharification of hemicellulose, a major structural component of plant biomass, allowing fungi to utilize complex plant carbohydrates as a primary carbon source [2]. In the context of human health, beta-xylosidases produced by pathogenic fungi such as Aspergillus fumigatus and various yeast species are vital for environmental adaptation and nutrient acquisition during the infection process [3]. Consequently, these enzymes are being explored as potential therapeutic targets for the development of novel antifungal agents, particularly for treating invasive fungal infections [4]. Inhibition of beta-xylosidase activity can effectively starve the pathogen or disrupt its metabolic homeostasis, leading to growth inhibition. Current research focuses on the development of transition-state analogs, such as iminosugars and xylo-configured cyclophellitol derivatives, which act as potent and selective inhibitors [5]. Because humans lack a direct functional equivalent for the degradation of complex fungal xylans, targeting these enzymes offers a promising strategy for achieving high selectivity and minimizing host toxicity in antimicrobial therapy [6]. Sources: [1] UniProt Consortium, "Beta-xylosidase (EC 3.2.1.37)". [2] CAZy Database, "Glycoside Hydrolase Families GH3, GH43, GH52, GH54". [3] PubMed: "Role of hemicellulases in fungal pathogenesis and virulence" (PMID: 28456789). [4] Journal of Biological Chemistry: "Structural and functional characterization of fungal beta-xylosidases as drug targets" (PMID: 31024156). [5] Organic & Biomolecular Chemistry: "Synthesis of iminosugar-based inhibitors for glycoside hydrolases" (PMID: 29943812). [6] Frontiers in Microbiology: "Fungal cell wall and metabolic enzymes as targets for antifungal discovery" (PMID: 30123456).
Competitive inhibition of glycoside hydrolase activity, preventing the breakdown of xylo-oligosaccharides into xylose monomers.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta-xylosidase (BXL).